The ET1 peptide is elevated in patients suffering from sickle cell disease, which is associated with episodes of severe pain and animal studies showed that absence of the ETA receptor subtype blocked sickle cells disease-related pain behavior (Lutz et al., 2018). The gene discussed is EDN1; the disease is sickle cell disease.